|
Hematologic Malignancy Grand Rounds - FY18 The Curious Case of the Vanishing Neoplasm |
02/23/2018 - 9:00am to 10:00am EST |
|
Hematologic Malignancy Grand Rounds - FY18 The Dilemma of CTCL |
03/16/2018 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 The Goldilocks Zone for Immunotherapy in Acute Myeloid Leukemia |
09/15/2017 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 The LAST Study: Life After Stopping TKI’s |
02/16/2018 - 9:00am to 10:00am EST |
|
Hematologic Malignancy Grand Rounds - FY18 The Power of Natural Killer Cells and the Future of AML Treatment |
10/06/2017 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 Tough cases Autoimmune Neuromuscular Disorders and Others |
05/04/2018 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 Treatment of Acute Myeloid Leukemia: Did the standard of care change in the summer of ’17? |
11/17/2017 - 9:00am to 10:00am EST |
|
Hematologic Malignancy Grand Rounds - FY18 Triple Trouble A Case from the Lymphoma Clinic |
06/15/2018 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 Viral Lymphoma Which do you treat |
04/27/2018 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 When standard treatment for rare disease fails- what next |
03/30/2018 - 9:00am to 10:00am EDT |
Facebook
Twitter
LinkedIn
Forward